Navigation Links
'Heart' of Herschel to be presented to media

By the end of 2007, the assembly of the ESA's Herschel far-infrared space observatory - the latest mission to study the formation and evolution of stars and galaxies - will be completed.

ESA and Astrium are jointly inviting the media to a press conference in Friedrichshafen, Germany, on 19 September 2007, to hear about this revolutionary spacecraft, its scientific objectives, and to view the very heart of its hardware.

The Herschel mission, equipped with the largest telescope ever launched in space (3.5 m diameter), will give astronomers their best capability yet to explore the universe at far-infrared and sub-millimetre wavelengths. By measuring the light at these wavelengths, scientists see the 'cold' universe. Herschel will give them an unprecedented view, allowing them to see deep into star forming regions, galactic centres and planetary systems.

In order to achieve its objectives and to be able to detect the faint radiation coming from the coolest objects in the cosmos, otherwise 'invisible', Herschel's detectors must operate at very low and stable temperatures. The spacecraft is equipped so as to cool them close to absolute zero (-273.15 C), ranging from -271 C to only a few tenths of a degree above absolute zero. To have achieved this particular feature alone is a remarkable accomplishment for European industry and science.

The final integration of the various components of the Herschel spacecraft - payload module, cryostat, service module, telescope and solar arrays - will be completed in the next few months. This phase will be followed by a series of tests to get the spacecraft ready for launch at the end of July 2008. Herschel will be launched into space on an Ariane 5 ECA rocket. The launch is shared with Planck, ESA's mission to study relic radiation from the Big Bang.


Contact: ESA Media Relations Office
European Space Agency

Page: 1

Related biology news :

1. HIV Patients May Be at Risk of Heart Problems When Taking Protease Inhibitor Drugs
2. UCSD team discovers specialized, rare heart stem cells in newborns
3. Implanted Devices Detect High-Risk Heart Failure Patients
4. Rush Physicians Using Gene Therapy For Heart Patients With Moderate To Severe Chest Pains Who Do Not Benefit From Other Treatments
5. Special Imaging Study Shows Failing Hearts Are Energy Starved
6. Stem Cell Research Shows Potential for Replacing Tissue Damaged in Heart Attacks
7. Single stem cells from bone heal a broken heart
8. Heart repair gets new muscle
9. Python a hearty eater
10. Columbia study shows widely used artery clearing device does not help patients during heart attack
11. Researchers reveal secret of key protein in brain and heart function
Post Your Comments:
(Date:11/10/2015)... , Nov. 10, 2015 ... biometrics that helps to identify and verify the ... is considered as the secure and accurate method ... of a particular individual because each individual,s signature ... results especially when dynamic signature of an individual ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has been ... provide preclinical development services to the National Cancer Institute ... will provide scientific expertise, modern testing and support facilities, ... preclinical pharmacology and toxicology studies to evaluate potential cancer ... The PREVENT Cancer Drug Development Program is an ...
(Date:10/29/2015)... Mich. , Oct. 29, 2015  Rubicon ... Genomics for U.S. distribution of its DNA library ... kit and Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX ... enable the preparation of NGS libraries for liquid ... for diagnostic and prognostic applications in cancer and ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... SAN DIEGO , Nov. 25, 2015 ... that management will participate in a fireside chat discussion ... New York . The discussion is ... Time. .  A replay will ... Contact:  Media Contact:McDavid Stilwell  , Julie NormartVP, Corporate ...
(Date:11/24/2015)... KUALA LUMPUR, Malaysia , Nov. 24, 2015 ... the global contract research organisation (CRO) market. The ... to result in lower margins but higher volume ... With increased capacity and scale, however, margins in ... Contract Research Organisation (CRO) Market ( ...
(Date:11/24/2015)... , Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... in New York on Wednesday, December 2 ... Torley , president and CEO, will provide a corporate overview. ... York at 1:00 p.m. ET/10:00 a.m. PT . ... relations, will provide a corporate overview. --> th ...
(Date:11/24/2015)... Tampa, Florida (PRWEB) , ... November 24, 2015 ... ... its biggest event of the year and one of the premier annual events ... USA, and ran from 8–11 November 2015, where ISPE hosted the largest number ...
Breaking Biology Technology: